If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Medical Affairs Excellence
Download FREE Excerpt
14 Info Graphics
42 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Biotech; Laboratories; Biopharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Non-Profit; Chemical; Consulting; Communications; Clinical Research; Education
Adamas Pharmaceuticals; Alcon Laboratories; Alkem; Arena Pharmaceuticals; Astellas; AstraZeneca; AveXis; Bayer; Biogen; CCPE-CFPC: Council for Continuing Pharmaceutical Education; Dendreon Pharmaceuticals LLC; Eisai; EMD Serono; Endo Pharmaceuticals; Ferring Pharmaceuticals; Fidia; Gedeon Richter ; Genentech; Heron Therapeutics; Indegene; Ipsen; IQVIA; Karyopharm Therapeutics; Mallinckrodt; MEDiSTRAVA; Merck; NexGen Healthcare Communications; Novartis; Novo Nordisk; Pfizer; PTC Therapeutics; Inc.; Retrophin; Rhythm Pharmaceuticals; Sanofi; Sanofi Genzyme; Sunovion; Terumo Corporation; Teva Pharmaceutical Industries Ltd; TG Therapeutics; UCB Pharma; United Therapeutics; Versant Learning Solutions
Best Practices, LLC engaged 57 Medical Affairs leaders involved with Medical Affairs training at 42 bio-pharmaceutical companies. In-depth interviews were conducted with 5 benchmark partners to highlight often-used training practices. Over 60% of participants are Medical Affairs Directors or Heads.
Data is segmented on the basis of function maturity to offer a clear understanding of training practices and trends.
Key topics covered in this report include: